Diabetes Metabolism Research and Reviews (DMRR) is a scholarly journal dedicated to publishing research in the field of Medicine. John Wiley and Sons is the publisher of this esteemed journal. The P-ISSN assigned to Diabetes Metabolism Research and Reviews is 1520-7552 and its abbreviated form is Diabetes Metab Res Rev.
Diabetes/Metabolism Research and Reviews is an indispensable resource for clinicians and researchers working in the fields of diabetes, endocrinology, metabolism and obesity. Our reviews section provides the latest updates on clinical and basic scientific advances in key areas of diabetes, obesity and metabolism, important historical overviews, discussion of controversial issues and opinions from prominent researchers and clinicians. Original articles describing clinical studies, translational and basic research related to diabetes, obesity, metabolism, or closely related metabolic disorders are welcome, as are articles concerned with treatment and management issues related to patient care.
Journal title | Diabetes Metabolism Research and Reviews (DMRR) |
Abbreviation | Diabetes Metab Res Rev |
Print ISSN | 1520-7552 |
Online ISSN | 1520-7560 |
Publisher Name | John Wiley and Sons |
Editor-in-chief | Paolo Pozzilli |
Subject Category | Medicine |
Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Diabetes Metabolism Research and Reviews Journal is Diabetes Metab Res Rev.
The Ranking of the Journal in 2024 is 1488. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 8. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 1.863. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Acceptance Rate in 2024 is 14%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.
The Journal's H-Index in 2024 is 124. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
✅ | ✅ | ✅ | ✅ | ❌ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Diabetes Metab Res Rev |
Access type | Hybrid |
Acceptance rate | 14% |
Impact Factor | 8 |
SJR | 1.863 |
SNIP | 2.396 |
Ranking | 1488 |
CiteScore | 15.1 |
H-Index | 124 |
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is 4,550 USD, 2,980 GBP, 3,790 EUR
Call for paper : The Journal invites original research contributions for consideration of publication in Diabetes Metabolism Research and Reviews journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Diabetes Metabolism Research and Reviews involves the following steps:
Yes, the journal is indexed in PubMed.
Yes, the journal is indexed in Scopus.
Yes, the journal is indexed in UGC.
No, the journal is not indexed in Index copernicus.
No, journal is not a predatory journal.
The Impact Factor of the Journal is 8.
The Ranking of the Journal is 1488.
Yes the journal is a peer-reviewed journal.
Yes the journal is a peer-reviewed journal and good to publish your paper.
Diabetes Metabolism Research and Reviews (DMRR) is a scholarly journal dedicated to publishing research in the field of Medicine. John Wiley and Sons is the publisher of this esteemed journal.
Yes, Diabetes Metabolism Research and Reviews is a open access (Hybrid) journal.